Buy Constellium Ahead of Q2: Valuation Edge Meets Operational Momentum
Constellium (CSTM) offers a tactical long opportunity ahead of Q2 results: reasonable valuation (P/E ~11-12, EV/EBITDA ~7.1), a $300M buyback authorization, and fresh aerospace demand from a multi-year Airbus deal. Enter near $36.76, target $42.00, stop $33.00 for a mid-term trade over the next 45 trading days.